Safety and efficacy of new potassium binders on hyperkalemia management in patients with heart failure: a systematic review and meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Safety and efficacy of new potassium binders on hyperkalemia management in patients with heart failure: a systematic review and meta-analysis of randomized controlled trials

Published:2023-05-04 Issue:7 Volume:112 Page:991-1002
ISSN:1861-0684
Container-title:Clinical Research in Cardiology
language:en
Short-container-title:Clin Res Cardiol

Author:

Carvalho Pedro E. P.^ORCID,Veiga Thiago M. A.,Lacerda Henrique,Tofanelli Matheus R.,Gewehr Douglas M.,Nunes Maria C. P.,Simões e Silva Ana C.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00392-023-02215-2.pdf

Reference37 articles.

1. Pitt B, Zannad F, Remme WJ et al (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 341(10):709–717. https://doi.org/10.1056/NEJM199909023411001

2. Ay J, Ohn NC, Ianni G et al (2001) A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 345(23):1667–1675. https://doi.org/10.1056/NEJMOA010713

3. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316(23):1429–1435. doi:https://doi.org/10.1056/NEJM198706043162301

4. McMurray JJV, Packer M, Desai AS et al (2014) Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 371(11):132–133. https://doi.org/10.1056/NEJMOA1409077

5. Heidenreich PA, Bozkurt B, Aguilar D et al (2022) 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: a Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 145(18):E895–E1032. https://doi.org/10.1161/CIR.0000000000001063

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coste-efectividad del ciclosilicato de sodio y zirconio para el tratamiento de la hiperpotasemia en pacientes con enfermedad renal crónica o insuficiencia cardiaca en España;Nefrología;2024-09

2. Is patiromer a safe and effective treatment for hyperkalemia in patients with heart failure (HF) on goal-directed medical therapy?;Evidence-Based Practice;2024-05-07

3. Aortic regurgitation is associated with African American and Asian race, smoking, renal disease, and numerous autoimmune diseases in addition to traditional cardiovascular risk factors but has lower risk with alcohol intake;Clinical Research in Cardiology;2024-03-13

4. Novel potassium binders to optimize RAASi therapy in heart failure: A systematic review and meta-analysis;European Journal of Internal Medicine;2024-01

5. The efficacy and safety of new potassium binders on renin–angiotensin–aldosterone system inhibitor optimization in heart failure patients: a systematic review and meta‐analysis;ESC Heart Failure;2023-11-27